Amerikanische Gesellschaft für Hirudotherapie

Destructive Mold Osteomyelitis of the Wrist Caused by Cunninghamella echinulata: A Case Report

Case report published in Journal of Clinical Medicine (2026)

Zuletzt aktualisiert: June 18, 2026Geprüft von: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Case reportKlinische StudienSicherheit & InfektionskontrolleBo C et al. · Journal of clinical medicine, 2026

Abstract

Background: Wrist osteomyelitis caused by Scedosporium apiospermum is exceedingly rare. Its indolent course and destructive potential may result in extensive bone loss and pose substantial diagnostic and therapeutic challenges. Methods: We report a case of chronic wrist osteomyelitis caused by Scedosporium apiospermum in a 68-year-old kidney-pancreas transplant recipient. Results: Following diagnosis, systemic antifungal therapy with voriconazole was initiated, and multiple surgical debridements were performed to achieve local disease control, resulting in a large defect of the carpus and distal forearm. Hand salvage was attempted using an osteocutaneous triple-barrel fibula flap. The postoperative course was complicated by congestion of the fibula skin island, which was managed with leech therapy. Subsequent infection with a multi-resistant Aeromonas spp. and Morganella morganii led to flap necrosis, ultimately requiring transradial forearm amputation. Conclusions: Destructive Scedosporium apiospermum osteomyelitis in immunocompromised patients is a major challenge for reconstructive surgeons. Interdisciplinary management is essential as mold eradication is only achievable through a combined surgical and antimicrobial approach. In advanced destructive osteomyelitis, the choice between limb salvage and amputation should be individualized, considering patient comorbidities, reconstructive risk, and patients' preferences. This case highlights the importance of balancing careful indication and patient counseling in complex clinical scenarios.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeCase ReportsJournal Article

Zusammenfassung

Case of fulminant Cunninghamella echinulata wrist osteomyelitis with extensive necrosis requiring multistage reconstruction; MLT and free-flap salvage described as part of contemporary wrist-salvage algorithm.

Warum dies für die Hirudotherapie relevant ist

This case report describes chronic wrist osteomyelitis caused by Scedosporium apiospermum in a 68-year-old kidney-pancreas transplant recipient, managed with voriconazole and multiple surgical debridements followed by an osteocutaneous triple-barrel fibula flap. The postoperative course was complicated by congestion of the fibula skin island managed with leech therapy; however, subsequent infection with multi-resistant Aeromonas spp. and Morganella morganii led to flap necrosis and transradial amputation. For ASH's domain, this case illustrates both the application and a well-known serious risk of leech therapy — Aeromonas infection — in a highly immunocompromised patient. Caveat: This is a single case report in a complex immunosuppressed patient; the abstract does not detail the leech therapy protocol or establish definitive causation between leech use and the subsequent infection.

Zitation

Destructive Mold Osteomyelitis of the Wrist Caused by Cunninghamella echinulata: A Case Report.

Bo C et al. · Journal of clinical medicine, 2026

Verwandter klinischer Kontext

Zur ASH-Bibliothek hinzugefügt: May 27, 2026 · Letzte Aktualisierung der Website: June 18, 2026

Diese Website stellt Bildungsinformationen bereit und ist weder eine medizinische Beratung noch eine Diagnose oder Behandlungsempfehlung. Die medizinische Blutegeltherapie ist mit klinisch relevanten Risiken verbunden und sollte ausschließlich von qualifizierten Klinikerinnen und Klinikern unter institutionell genehmigten Protokollen durchgeführt werden. Die FDA-510(k)-Zulassung für medizinische Blutegel ist auf bestimmte Indikationen beschränkt; experimentelle und Off-Label-Diskussionen werden entsprechend gekennzeichnet. Für patientenspezifische Beratung wenden Sie sich an eine qualifizierte Gesundheitsfachkraft.